At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
ASPIRE Interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ASPIRE: Adapting Self-Blood Pressure Monitoring to Reduce Health Disparities
In Brief
A clinical study evaluating ASPIRE Intervention for Hypertension. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The goal of this study is to implement a pilot focusing on developing training manuals and materials for patients and the clinical team to ensure our intervention is delivered consistently and systematically for each patient.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedDec 2023
Enrollment StartJan 2024
Primary CompletionMay 2024
TodayJul 2026
First PostedDec 19, 2023
Enrollment StartJan 15, 2024
Primary CompletionMay 31, 2024
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 2.5 years ago
Interventions
ASPIRE Interventionbehavioral
In addition to usual care and a free blood pressure cuff, participants in the intervention arm will receive the ASPIRE components: (1) ASPIRE Tool Kit, (2) ASPIRE Coach, (3) SMBP EHR Documentation, and (4) screening and addressing SDOHs.